Related Experiment Video
Updated: May 21, 2026

08:07
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
In-home walking speeds and variability trajectories associated with mild cognitive impairment
H H Dodge1, N C Mattek, D Austin
1Oregon Center for Aging and Technology, Department of Neurology, Oregon Health & Science University, Portland, OR, USA. dodgeh@ohsu.edu
Neurology
|June 13, 2012
Summary
Long-term in-home monitoring of walking speed and its variability can identify mild cognitive impairment (MCI) in older adults. These gait changes may signal early transitions toward dementia.
Area of Science:
- Gerontology
- Neurology
- Biomedical Engineering
Background:
- Mild cognitive impairment (MCI) is a transitional stage between normal cognition and dementia.
- Early detection of MCI is crucial for timely intervention and management.
- Objective, unobtrusive, long-term monitoring methods are needed to assess cognitive decline in real-world settings.
Purpose of the Study:
- To investigate if unobtrusive, long-term in-home assessment of walking speed and its variability can differentiate individuals with MCI from those with intact cognition.
- To explore the potential of gait parameters as early biomarkers for cognitive impairment.
Main Methods:
- Utilized passive infrared sensors in participants' homes to continuously monitor walking speed.
- Analyzed weekly mean walking speed and walking speed variability (coefficient of variation [COV]) using latent trajectory models.
- Included elderly participants from the Intelligent Systems for Assessing Aging Change (ISAAC) cohort study.
Main Results:
- Identified three distinct trajectories for mean weekly walking speed (fast, moderate, slow).
- Individuals with nonamnestic MCI (naMCI) were more likely to exhibit slower walking speeds.
- Identified four distinct trajectories for walking speed variability (COV), with naMCI participants showing patterns of highest or lowest baseline COV.
Conclusions:
- Walking speed and its daily variability show promise as early indicators of MCI development.
- Real-time gait measures may offer novel methods for detecting the transition phases leading to dementia.
- Passive in-home monitoring provides a feasible approach for long-term assessment of functional changes related to cognitive health.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

